Ekso Bionics Holdings, Inc.
EKSO
$12.40
$0.403.33%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -28.60% | -16.59% | -19.32% | -2.06% | -1.94% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -28.60% | -16.59% | -19.32% | -2.06% | -1.94% |
| Cost of Revenue | -29.24% | -19.43% | -18.80% | -7.94% | -8.54% |
| Gross Profit | -28.03% | -13.94% | -19.81% | 3.72% | 4.76% |
| SG&A Expenses | 0.81% | -5.53% | -2.50% | -9.73% | -15.37% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.24% | -12.76% | -11.20% | -12.02% | -14.99% |
| Operating Income | -18.51% | 6.95% | -1.11% | 24.83% | 30.78% |
| Income Before Tax | -3.22% | 6.26% | 10.78% | 24.20% | 25.45% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.22% | 6.26% | 10.78% | 24.20% | 25.45% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.22% | 6.26% | 10.78% | 24.20% | 25.45% |
| EBIT | -18.51% | 6.95% | -1.11% | 24.83% | 30.78% |
| EBITDA | -22.27% | 6.87% | -2.25% | 27.36% | 34.01% |
| EPS Basic | 42.08% | 43.20% | 44.73% | 49.73% | 48.27% |
| Normalized Basic EPS | 45.46% | 43.74% | 45.19% | 50.14% | 48.84% |
| EPS Diluted | 42.08% | 43.53% | 44.99% | 49.93% | 48.46% |
| Normalized Diluted EPS | 45.46% | 43.74% | 45.19% | 50.14% | 48.84% |
| Average Basic Shares Outstanding | 80.44% | 73.26% | 60.59% | 48.67% | 45.34% |
| Average Diluted Shares Outstanding | 80.44% | 73.26% | 60.59% | 48.67% | 45.34% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |